Details for New Drug Application (NDA): 078625
✉ Email this page to a colleague
The generic ingredient in LAMOTRIGINE is lamotrigine. There are thirty-two drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lamotrigine profile page.
Summary for 078625
Tradename: | LAMOTRIGINE |
Applicant: | Rubicon |
Ingredient: | lamotrigine |
Patents: | 0 |
Pharmacology for NDA: 078625
Mechanism of Action | Dihydrofolate Reductase Inhibitors Organic Cation Transporter 2 Inhibitors |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 078625
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078625 | ANDA | REMEDYREPACK INC. | 70518-3602 | 70518-3602-0 | 30 TABLET in 1 BLISTER PACK (70518-3602-0) |
LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078625 | ANDA | REMEDYREPACK INC. | 70518-3602 | 70518-3602-1 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-3602-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Jan 27, 2009 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Jan 27, 2009 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
Approval Date: | Jan 27, 2009 | TE: | AB | RLD: | No |
Complete Access Available with Subscription